AGT and fibrosis: Consistent with previous studies (Su et al., 2017; Schafer et al., 2017), Ang II treatment induced cardiac fibrosis with increasing the ratio of heart weight to tibial length and fibrosis area and impaired EF and FS (Figure 1B–D).